Kalies K, Knopp K, Koch S, Pilowski C, Wurmbrand L, Sedding D
PLoS One. 2025; 20(2):e0319381.
PMID: 40019880
PMC: 11870368.
DOI: 10.1371/journal.pone.0319381.
Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A
Mol Cancer. 2025; 24(1):58.
PMID: 40011944
PMC: 11863469.
DOI: 10.1186/s12943-025-02267-0.
Sierra J, de Leon U, Padilla-Longoria P
Mol Cell Biochem. 2025; .
PMID: 39827422
DOI: 10.1007/s11010-025-05205-2.
Malik M, Dashti M, Jangid A, Channanath A, John S, Brojen Singh R
Brief Bioinform. 2025; 26(1.
PMID: 39820247
PMC: 11736902.
DOI: 10.1093/bib/bbae706.
He R, Liu Y, Fu W, He X, Liu S, Xiao D
Mol Cancer. 2024; 23(1):267.
PMID: 39614268
PMC: 11606237.
DOI: 10.1186/s12943-024-02172-y.
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma.
Otsuji R, Hata N, Yamamoto H, Kuga D, Hatae R, Sangatsuda Y
Neurooncol Adv. 2024; 6(1):vdae069.
PMID: 39022644
PMC: 11252564.
DOI: 10.1093/noajnl/vdae069.
Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them.
Xu Z, Zhang N, Shi L
Am J Cancer Res. 2024; 14(6):2666-2694.
PMID: 39005671
PMC: 11236784.
DOI: 10.62347/OEGE2648.
The cell cycle regulator p16 promotes tumor infiltrated CD8 T cell exhaustion and apoptosis.
Zhang X, Wang J, Tang K, Yang Y, Liu X, Yuan S
Cell Death Dis. 2024; 15(5):339.
PMID: 38750022
PMC: 11096187.
DOI: 10.1038/s41419-024-06721-7.
Understanding the complexity of p53 in a new era of tumor suppression.
Liu Y, Su Z, Tavana O, Gu W
Cancer Cell. 2024; 42(6):946-967.
PMID: 38729160
PMC: 11190820.
DOI: 10.1016/j.ccell.2024.04.009.
Soft Tissue Sarcomas with Chromosomal Alterations in the 12q13-15 Region: Differential Diagnosis and Therapeutic Implications.
Lavernia J, Claramunt R, Romero I, Lopez-Guerrero J, Llombart-Bosch A, Machado I
Cancers (Basel). 2024; 16(2).
PMID: 38275873
PMC: 10814159.
DOI: 10.3390/cancers16020432.
Cellular carcinogenesis in preleukemic conditions:drivers and defenses.
Ueda K, Ikeda K
Fukushima J Med Sci. 2023; 70(1):11-24.
PMID: 37952978
PMC: 10867434.
DOI: 10.5387/fms.2023-17.
Spontaneous p53 activation in middle-aged C57BL/6 mice mitigates the lifespan-extending adaptive response induced by low-dose ionizing radiation.
Kohzaki M, Suzuki K, Ootsuyama A, Okazaki R
NPJ Aging. 2023; 9(1):26.
PMID: 37935713
PMC: 10630390.
DOI: 10.1038/s41514-023-00123-3.
Pathogenesis and therapeutic implications of EBV-associated epithelial cancers.
Low Y, Loh C, Peh D, Chu A, Han S, Toh H
Front Oncol. 2023; 13:1202117.
PMID: 37901329
PMC: 10600384.
DOI: 10.3389/fonc.2023.1202117.
The matrix microenvironment influences but does not dominate tissue-specific stem cell lineage differentiation.
Pei Y, Mikaeiliagah E, Wang B, Zhang X, Pei M
Mater Today Bio. 2023; 23:100805.
PMID: 37766896
PMC: 10519827.
DOI: 10.1016/j.mtbio.2023.100805.
The Long Non-Coding RNA ANRIL in Cancers.
Sanchez A, Lhuillier J, Grosjean G, Ayadi L, Maenner S
Cancers (Basel). 2023; 15(16).
PMID: 37627188
PMC: 10453084.
DOI: 10.3390/cancers15164160.
Role of p53 suppression in the pathogenesis of hepatocellular carcinoma.
Choudhary H, Mandlik S, Mandlik D
World J Gastrointest Pathophysiol. 2023; 14(3):46-70.
PMID: 37304923
PMC: 10251250.
DOI: 10.4291/wjgp.v14.i3.46.
Identification of p53-target genes in human papillomavirus-associated head and neck cancer by integrative bioinformatics analysis.
Bouzid A, Al Ani M, de la Fuente D, Al Shareef Z, Quadri A, Hamoudi R
Front Oncol. 2023; 13:1128753.
PMID: 37081989
PMC: 10110890.
DOI: 10.3389/fonc.2023.1128753.
Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types.
Sasaki K, Takahashi S, Ouchi K, Otsuki Y, Wakayama S, Ishioka C
Sci Rep. 2023; 13(1):4868.
PMID: 36964217
PMC: 10039000.
DOI: 10.1038/s41598-023-32092-8.
hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex.
Huang X, Zhao Y, Wei M, Zhuge R, Zheng X
J Mol Cell Biol. 2023; 15(2).
PMID: 36881716
PMC: 10476552.
DOI: 10.1093/jmcb/mjad015.
Update on Prognostic and Predictive Markers in Mucinous Ovarian Cancer.
Borella F, Mitidieri M, Cosma S, Benedetto C, Bertero L, Fucina S
Cancers (Basel). 2023; 15(4).
PMID: 36831515
PMC: 9954175.
DOI: 10.3390/cancers15041172.